GlassScriptPhysician profile
Dawn M Levasseur
NPI 1295159085
$3,035.77
in general payments reported to CMS, 2019-2025
23 companies · $39.57 in 2025
The $39.57 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $348 · 2022: $1,503 · 2023: $953 · 2024: $192 · 2025: $39.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,183.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $572.11 | 2022-2024 | |
| Astrazeneca Pharmaceuticals LP | $413.23 | 2021-2025 | Breztri, Farxiga |
| Abbvie INC. | $372.90 | 2022-2024 | |
| Novo Nordisk INC | $314.76 | 2021-2024 | Rybelsus, Ozempic, Wegovy |
| Astellas Pharma US INC | $267.31 | 2022-2024 | Veozah, Myrbetriq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $187.10 | 2022-2025 | Jardiance |
| Glaxosmithkline, LLC. | $154.11 | 2021-2023 | Trelegy Ellipta |
| Biohaven Pharmaceutical Holding Company LTD. | $99.16 | 2022 | |
| Novartis Pharmaceuticals Corporation | $95.52 | 2022-2023 | |
| Abbott Laboratories | $80.34 | 2022-2023 | Freestyle Libre 3 |
| Pfizer INC. | $66.88 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $54.15 | 2022-2023 | Austedo, Austedo Xr |
| Takeda Pharmaceuticals U.S.A., INC. | $51.71 | 2022 | |
| Lilly USA, LLC | $48.23 | 2021-2022 | |
| Eisai INC. | $47.59 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $46.91 | 2022 | |
| Exact Sciences Corporation | $45.95 | 2023 | Cologuard Collection Kit |
| Lundbeck LLC | $41.83 | 2022-2023 | Rexulti |
| Janssen Pharmaceuticals, INC | $19.78 | 2021 | |
| Sanofi Pasteur INC. | $18.00 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $17.04 | 2021 | |
| Nestle Healthcare Nutrition INC. | $16.14 | 2021 | |
| Corium, LLC | $5.02 | 2023 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dawn Levasseur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.